Whittier Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $137M | Sell |
148,096
-28,529
| -16% | -$28.9M | 1.55% | 11 |
|
|
2025
Q4 | $188M | Buy |
176,625
+37,103
| +27% | +$35.5M | 2.04% | 10 |
|
|
2025
Q3 | $117M | Buy |
139,522
+6,224
| +5% | +$4.63M | 1.33% | 13 |
|
|
2025
Q2 | $104M | Buy |
133,298
+16,551
| +14% | +$12.9M | 1.25% | 14 |
|
|
2025
Q1 | $96.4M | Buy |
116,747
+23,186
| +25% | +$19.3M | 1.34% | 14 |
|
|
2024
Q4 | $72.2M | Sell |
93,561
-10,363
| -10% | -$8.58M | 0.95% | 17 |
|
|
2024
Q3 | $92.1M | Buy |
103,924
+5,282
| +5% | +$4.75M | 1.23% | 14 |
|
|
2024
Q2 | $89.3M | Buy |
98,642
+23,155
| +31% | +$18.5M | 1.27% | 13 |
|
|
2024
Q1 | $58.7M | Buy |
75,487
+25,877
| +52% | +$18.4M | 0.86% | 22 |
|
|
2023
Q4 | $28.9M | Sell |
49,610
-10,227
| -17% | -$5.97M | 0.47% | 48 |
|
|
2023
Q3 | $32.1M | Buy |
59,837
+329
| +0.6% | +$170K | 0.57% | 41 |
|
|
2023
Q2 | $27.9M | Sell |
59,508
-711
| -1% | -$298K | 0.49% | 47 |
|
|
2023
Q1 | $20.7M | Buy |
60,219
+568
| +1% | +$192K | 0.38% | 69 |
|
|
2022
Q4 | $21.8M | Buy |
59,651
+449
| +0.8% | +$159K | 0.42% | 56 |
|
|
2022
Q3 | $19.1M | Buy |
59,202
+3,401
| +6% | +$1.08M | 0.4% | 64 |
|
|
2022
Q2 | $18.1M | Buy |
55,801
+897
| +2% | +$269K | 0.37% | 66 |
|
|
2022
Q1 | $15.7M | Buy |
54,904
+348
| +0.6% | +$89.6K | 0.27% | 92 |
|
|
2021
Q4 | $15.1M | Buy |
54,556
+759
| +1% | +$192K | 0.24% | 98 |
|
|
2021
Q3 | $12.4M | Buy |
53,797
+490
| +0.9% | +$121K | 0.23% | 105 |
|
|
2021
Q2 | $12.2M | Buy |
53,307
+40,019
| +301% | +$8.04M | 0.22% | 104 |
|
|
2021
Q1 | $2.48M | Sell |
13,288
-243
| -2% | -$47.5K | 0.05% | 245 |
|
|
2020
Q4 | $2.29M | Buy |
13,531
+476
| +4% | +$71.1K | 0.05% | 237 |
|
|
2020
Q3 | $1.93M | Hold |
13,055
| – | – | 0.05% | 245 |
|
|
2020
Q2 | $2.14M | Buy |
13,055
+269
| +2% | +$41.3K | 0.06% | 218 |
|
|
2020
Q1 | $1.77M | Sell |
12,786
-2,826
| -18% | -$388K | 0.06% | 224 |
|
|
2019
Q4 | $2.05M | Buy |
15,612
+548
| +4% | +$63.5K | 0.05% | 230 |
|
|
2019
Q3 | $1.68M | Buy |
15,064
+79
| +0.5% | +$8.79K | 0.05% | 243 |
|
|
2019
Q2 | $1.66M | Sell |
14,985
-500
| -3% | -$58.9K | 0.05% | 248 |
|
|
2019
Q1 | $2.01M | Buy |
15,485
+6
| +0% | +$730 | 0.06% | 222 |
|
|
2018
Q4 | $1.79M | Sell |
15,479
-440
| -3% | -$49.2K | 0.06% | 224 |
|
|
2018
Q3 | $1.71M | Buy |
15,919
+3,999
| +34% | +$400K | 0.05% | 241 |
|
|
2018
Q2 | $1.02M | Hold |
11,920
| – | – | 0.03% | 280 |
|
|
2018
Q1 | $922K | Hold |
11,920
| – | – | 0.03% | 293 |
|
|
2017
Q4 | $1.01M | Buy |
11,920
+268
| +2% | +$22.8K | 0.04% | 290 |
|
|
2017
Q3 | $997K | Buy |
11,652
+750
| +7% | +$61.5K | 0.04% | 280 |
|
|
2017
Q2 | $897K | Sell |
10,902
-68
| -0.6% | -$5.55K | 0.03% | 280 |
|
|
2017
Q1 | $923K | Buy |
10,970
+3,014
| +38% | +$241K | 0.04% | 276 |
|
|
2016
Q4 | $585K | Buy |
7,956
+1
| +0% | +$74 | 0.02% | 324 |
|
|
2016
Q3 | $638K | Hold |
7,955
| – | – | 0.03% | 313 |
|
|
2016
Q2 | $627K | Hold |
7,955
| – | – | 0.03% | 318 |
|
|
2016
Q1 | $573K | Sell |
7,955
-1,915
| -19% | -$145K | 0.03% | 328 |
|
|
2015
Q4 | $832K | Sell |
9,870
-1,007
| -9% | -$83.6K | 0.04% | 288 |
|
|
2015
Q3 | $910K | Sell |
10,877
-2,190
| -17% | -$185K | 0.04% | 262 |
|
|
2015
Q2 | $1.09M | Buy |
13,067
+2,058
| +19% | +$157K | 0.05% | 260 |
|
|
2015
Q1 | $800K | Buy |
11,009
+4,001
| +57% | +$285K | 0.04% | 287 |
|
|
2014
Q4 | $484K | Buy |
7,008
+18
| +0.3% | +$1.22K | 0.02% | 342 |
|
|
2014
Q3 | $453K | Hold |
6,990
| – | – | 0.02% | 344 |
|
|
2014
Q2 | $434K | Sell |
6,990
-166
| -2% | -$9.9K | 0.02% | 345 |
|
|
2014
Q1 | $421K | Hold |
7,156
| – | – | 0.02% | 340 |
|
|
2013
Q4 | $365K | Sell |
7,156
-1,950
| -21% | -$97.6K | 0.02% | 361 |
|
|
2013
Q3 | $458K | Hold |
9,106
| – | – | 0.02% | 342 |
|
|
2013
Q2 | $447K | Buy |
+9,106
| New | +$495K | 0.03% | 332 |
|
Other funds holding LLY
VCM
VPM
Whittier Trust's LLY Position: Q1 2026 in Review
Whittier Trust reduced its Eli Lilly (LLY) stake by 16% in Q1 2026, selling an estimated $28.9M and leaving 148,096 shares worth $137M. The position accounts for 1.55% of the portfolio, ranked #11.
Whittier Trust first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $188M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Whittier Trust held 148,096 shares of Eli Lilly worth $137M as of Q1 2026.
- Whittier Trust sold 28,529 Eli Lilly shares in Q1 2026, an estimated $28.9M.
- Eli Lilly made up 1.55% of Whittier Trust's portfolio in Q1 2026, its #11 holding.
- Whittier Trust first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Whittier Trust's Eli Lilly position peaked at $188M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Whittier Trust's 13F filing for Q1 2026, filed 28 Apr 2026.